NCT03258112

Safety and Efficacy of Catheter Ablation of Idiopathic Ventricular Arrhythmias Arising From Cardiac Outflow Tracts

Name: Clinical Trial NCT03258112
Creator: Assiut University
Keywords: Ventricular Arrythmia, Radiofrequency cardiac catheter ablation, procedure, clinical trial

Assiut University·ClinicalTrials.gov·procedureWithdrawn

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Ventricular Arrythmia
Drug/Device/Intervention: Radiofrequency cardiac catheter ablation
Study type: Interventional
Intervention type: procedure

Sponsor & location

Primary sponsor: Assiut University

Timeline & enrollment

Phase: N/A
Start date: Mar 01, 2017
End date: Nov 01, 2021
Enrollment: 0 participants

Primary outcome

procedural success

Summary

Ventricular arrhythmias arising from cardiac outflow tract affect quality of life and can cause decrease in left ventricular ejection fraction.  Drugs used for treating those arrhytmias may be ineffective or may have side effects.  Radiofrequency catheter ablation can be used safely for treatment of outflow tract arrhythmias.  There are different sites where those ventricular arrhythmias may originates, each site has different electrocardiographic characteristics, different procedural success rates and challenges in localization and ablation.

ICD-10 classifications

Ventricular tachycardiaLeft ventricular failureVentricular septal defectCardiomyopathy, unspecifiedCardiac arrhythmia, unspecified

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT03258112
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT03258112 through Pure Global AI's free database. This phase not specified trial is sponsored by Assiut University and is currently Withdrawn. The study focuses on Ventricular Arrythmia. Target enrollment is 0 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.